MOTION SICKNESS- dimenhydrinate tablet

Motion Sickness by

Drug Labeling and Warnings

Motion Sickness by is a Otc medication manufactured, distributed, or labeled by Strategic Sourcing Services LLC, LNK International, Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient (in each tablet)

Dimenhydrinate 50 mg

Purpose

Antiemetic

Uses

for prevention and treatment of these symptoms associated with motion sickness:

• nausea
• vomiting
• dizziness

Warnings

Do not use

for children under 2 years of age unless directed by a doctor.

Ask a doctor before use if you have

• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• difficulty in urination due to enlargement of the prostate gland 

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

• alcohol, sedatives, and tranquilizers may increase drowsiness
• marked drowsiness may occur
• use caution when driving a motor vehicle or operating machinery
• avoid alcoholic beverages
  

If pregnant or breast-feeding,

ask a health professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. 

Directions

• to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity

• adults and children 12 years and over: 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor
• children 6 to under 12 years: ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor
• children 2 to under 6 years: ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor

Other information

• each tablet contains: calcium 35 mg
• TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
• store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
• protect from moisture
• see end flap for expiration date and lot number

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid 

Questions or comments?

Call 833-358-6431 Monday to Friday 9:00am to 7:00pm EST

Principal Display Panel

NDC: 70677-1087-1

COMPARE TO DRAMAMINE®
ORIGINAL FORMULA ACTIVE INGREDIENT*

Foster & Thrive™

Motion Sickness

Dimenhydrinate 50 mg
ANTIEMETIC

Prevents:
Nausea Vomiting Dizziness
for Children & Adults

ACTUAL SIZE
12 TABLETS

*This product is not manufactured or distributed by Medtech Products Inc.,
owner of the registered trademark Dramamine® Original Formula.
50844 REV0518A19802  Rev. 10/23

Distributed by: McKesson Corp., via Strategic Sourcing
Services LLC., Memphis, TN 38141
Money Back Guarantee
www.fosterandthrive.com

©2023 McKesson Corporation

TAMPER EVIDENT: DO NOT USE IF PACKAGE IS
OPENED OR IF BLISTER UNIT IS TORN, BROKEN
OR SHOWS ANY SIGNS OF TAMPERING

Foster and thrive 44-198

INGREDIENTS AND APPEARANCE

MOTION SICKNESS 
dimenhydrinate tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70677-1087
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM)	DIMENHYDRINATE	50 mg

Inactive Ingredients
Ingredient Name	Strength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
STEARIC ACID (UNII: 4ELV7Z65AP)

Product Characteristics
Color	white	Score	2 pieces
Shape	ROUND	Size	9mm
Flavor		Imprint Code	44;198
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70677-1087-1	2 in 1 CARTON	05/04/2023
1		6 in 1 BLISTER PACK; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M009	05/04/2023

Labeler - Strategic Sourcing Services LLC (116956644)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		038154464	pack(70677-1087)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		832867837	manufacture(70677-1087) , pack(70677-1087)

Establishment
Name	Address	ID/FEI	Business Operations
LNK International, Inc.		117025878	manufacture(70677-1087)